Urinary AD7c-NTP Evaluates Cognition Impairment and Differentially Diagnoses AD and MCI,American Journal of Alzheimer's Disease and other Dementias

当前位置： X-MOL 学术 › Am. J. Alzheimers Dis. Other Demen. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Urinary AD7c-NTP Evaluates Cognition Impairment and Differentially Diagnoses AD and MCI
American Journal of Alzheimer's Disease and other Dementias ( IF 2.7 ) Pub Date : 2022-07-14 , DOI: 10.1177/15333175221115247
Ming-Ran Xu ₁ , Rong-Fang Dai ₂ , Qing-Qi Wei ₁ , Jun Wang ₁ , Yue-Ying Feng ₂ , Ying Hu ₁

Affiliation

The AD7c-NTP is a promising biomarker for AD diagnosis. However, the exact urinary AD7c-NTP concentration to differentiate AD from the mild cognitive impairment (MCI) remains inconclusive. We enrol...

中文翻译：